ArticleBiochemical pharmacology2008

The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-kappaB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats.

A Ochaion et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.